Who Shouldn't Start
Before the first 12-hour window — not after — run the pre-screen. Fasting is not for everyone: pregnancy, an eating-disorder history, being underweight, type-1 diabetes on insulin, and certain medications put the schedule in clinician territory. This page is a screening list, not a diagnosis: it tells you when to ask a clinician by name, and it does not decide for them.
What the evidence supports
- The published trials deliberately excluded pregnancy, eating-disorder history, underweight, and insulin-treated diabetes — the exclusion criteria are the safety list.
- Insulin and sulfonylureas lower blood glucose by design; skipping meals with those drugs on board is associated with hypoglycemia risk that is well documented.
- Fasting behavior in people with eating-disorder history is associated with relapse risk; clinical guidance consistently avoids prescribing it in that group.
What remains uncertain
- Where the safe boundary sits for milder conditions — hypertension on one medication, for example — is decided per person, not per guideline.
- How many people quietly fast through a condition they should have screened for; the trials cannot count what they excluded.
Evidence last reviewed: August 21, 2026. Conclusions may change as new research is published.
This Page Comes First
Every fasting trial on this site — TREAT, the NEJM 2022 calorie-restriction comparison, the 2023 16:8 trial — started by excluding people. Those exclusion criteria are not administrative noise; they are the accumulated clinical knowledge of who should not be randomized into a fasting schedule. The series lead keeps the same list in short form, Part 6 of the series owns the hormone-level detail, and this page turns the list into a usable pre-screen: read it, check yourself honestly, and let it decide whether the clock rule is yours.
The Pre-Screen List
Any single item on this list changes the default answer from "start at 12 hours" to "ask a clinician first" — and for several, the likely answer is "do not start at all." The table is the list; the section after it is the reasoning.
| Group | Why the caution | Default move |
|---|---|---|
| 🤰 Pregnancy or breastfeeding | Nutrient and glucose demands are not yours to schedule | Do not start |
| 🧠 Eating-disorder history | Fasting is associated with relapse risk in this group | Do not start |
| ⚖️ Underweight or unintended weight loss | The window removes calories a body may already lack | Do not start |
| 💉 Type-1 diabetes on insulin | Hypoglycemia risk rises when meals move, not just when they disappear | Clinician decision |
| 💊 Medications requiring food | Some drugs need meals for absorption or glucose safety | Ask first |
| 🩺 Chronic conditions in treatment | Blood-pressure, kidney, liver, and heart regimens interact with fasting | Ask first |
| 🧒 Children and teenagers | Growing bodies are not the audience for this protocol | Not for growth |
The Conditions, One by One
- 🤰 Pregnancy and breastfeeding: energy and nutrient demands are tied to the pregnancy, not to your schedule. No extended windows here — the series lead says it plainly: nutrition timing belongs to the pregnancy.
- 🧠 Eating-disorder history: fasting hands a structured permission slip to the very pattern you may be managing — skipping meals, earning food, controlling intake in private. Clinical guidance consistently treats this group as a no-go, and this site does the same, without judgment and without exception.
- ⚖️ Underweight, or weight dropping without trying: the window's main effect is fewer calories, which is precisely the wrong direction. If weight is already low or falling, the question to ask a clinician is about the weight, not about the window.
- 💉 Type-1 diabetes on insulin: insulin doses are matched to food; move the food and the match breaks. Hypoglycemia is the documented risk, and it can arrive hours after the skipped meal. Type-2 diabetes on certain drugs is a milder but real version of the same conversation. This table row is a clinician decision, not an internet decision.
- 🧒 Growing bodies: adolescents are building tissue on a schedule of their own. The never-fast list in Part 6 of the series covers the hormone and growth detail; the short version is that children are never part of anyone's eating window.
Medications: The Quiet Contraindication
The least-discussed pre-screen item is the medicine cabinet, because it never makes the fasting forums. If you take anything daily, the safe sequence is: list the drugs, check whether each one needs food, and ask the pharmacist or prescriber what happens when a meal moves. The pre-screen is not complete until that conversation happens — or until you know for certain that no drug on the list cares about meal timing. Part 6 of the series covers the medication and hormone detail in full.
- 💉 Insulin and sulfonylureas: built to lower blood glucose; with a skipped or late meal they are associated with hypoglycemia — dizziness, confusion, collapse. Verify dose timing with the clinician, not with a forum.
- ❤️ Blood-pressure medications: fasting can lower both intake and blood pressure together; lightheadedness and fainting are the reported experiences. If you take BP drugs, the window question belongs in the clinic.
- 🍞 Drugs that bind to food: some medications need a meal for absorption or to protect the stomach. Moving the meal moves the drug — ask before you do.
- 🧂 Electrolytes and hydration: not a medication, but the same rule: fasting changes sodium and fluid balance; people on diuretics or low-sodium regimens should treat this as a clinician conversation too.
Warning Signs to Stop and Ask
- 🚩 Fainting or near-fainting: any episode — stop fasting that day and ask a clinician. This is not a willpower problem.
- 🚩 Constant headache that does not clear: hydration and a pinch of salt help some people; persistence or worsening is a stop-and-ask signal, not a badge of effort.
- 🚩 Heart pounding on waking: a documented fasting stress response in some people; let a clinician sort stress from rhythm before continuing anything.
- 🚩 Food thoughts take over: if the window becomes the day's main event — planning, longing, sneaking — that is the pattern the pre-screen exists to catch, in people with and without prior history. Stop and talk to someone.
- 🚩 Weight loss you did not intend: the window is supposed to serve your goals, not override them. Unexplained loss is a clinician conversation, full stop.
What to Bring to the Conversation
Clinicians are busy, and "can I do intermittent fasting?" invites a shrug. Bring specifics instead: the exact window (14:10, say), the medications list with doses, your weight trajectory over six months, and any history that belongs on this page. Ask two questions — "does any drug on this list require a meal?" and "is there a reason the overnight gap should stay short for me?" — and let the answers decide. That is the entire handoff, and it is what "clinician territory" means on this site: they decide, we never do.
If the Answer Is No
A no from the pre-screen is not a dead end — it is a redirection. Twelve-hour windows are the entire benefit for many people and may still be off the table; what remains is the nutrition that always mattered: protein at target, vegetables, sleep, and movement. Those four carry most of the health load on this site without a single skipped meal. The Nutrition pillar's Fasting & Time-Restricted Eating topic and the series lead both end in the same place: the window is a tool, and if the tool does not fit your body or your life, the rest of the protocol still does.
⚠️ Clinician territory — this page screens, it does not diagnose
Nothing here is a diagnosis, and no item on the list is a reason to stop or change any medication on your own. If any condition or medication applies to you, the fasting question belongs to a physician, an endocrinologist, an obstetrician, or a dietitian — whichever owns your care. When in doubt, the default answer is no window until you have asked. The full hormone-level safety chapter is Part 6 of the series, and the companion list for women, thyroid, and athletes lives there.
Questions About the Pre-Screen
- ❓ I fit none of these — do I still need a clinician? — A healthy adult starting at 12 hours and rumbling up to 16 may reasonably proceed. The pre-screen is the floor: anyone below it asks first.
- ❓ Type 2 diabetes — allowed? — It depends on the drugs, the glucose control, and the clinician. Some type-2 regimens tolerate windows well; insulin and sulfonylureas do not. This is the single most common reason a fasting plan needs a prescription-level review.
- ❓ What if I already started and then recognized myself on this page? — Stop the window, keep eating normally, and take the list to your clinician. Nothing about this page requires finishing the experiment first.
- ❓ Does the site ever say "this person definitely shouldn't fast"? — It says "clinician decision" and "do not start" for the listed groups, because the trials screened them out for a reason. Beyond the list, the answer is per-person, and that judgment belongs to the clinician — which is exactly the handoff this page exists to make.
The Bottom Line
- The exclusion criteria are the safety list. Every fasting trial screened out the same groups; that is clinical knowledge, not cautionary theater.
- Four groups should typically not start: pregnancy, eating-disorder history, underweight, and type-1 diabetes on insulin.
- Medications make it a clinician question. Insulin, sulfonylureas, BP drugs, and food-bound meds each change the answer per person.
- The pre-screen decides before the first window. And when it says no, the rest of the protocol — protein, sleep, movement — says yes.
Related Topics
- American Diabetes Association, "Standards of Care in Diabetes," Diabetes Care (2024)
- Lowe et al., "Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: The TREAT randomized clinical trial," JAMA Internal Medicine (2020)
- Cienfuegos et al., "Effects of 4- and 6-h time-restricted feeding on weight and cardiometabolic health: A randomized controlled trial in adults with obesity," Cell Metabolism (2020)
- Lin et al., "Time-restricted eating without calorie counting for weight loss in a racially diverse population: A randomized controlled trial," Annals of Internal Medicine (2023)